The burdens of the NIH Access Plan Policy appear to be likely to create unacceptable commercial risks and uncertainty for potential private sector partners, which, in turn, will chill interest in forming the partnerships necessary to commercialize products and services based on federally-funded inventions.
The NIH RFI identifies a new 'Access Plan' policy purporting to promote partnerships (licenses) that will 'improve[] health for all' (hence 'equity through access') to 'provide a return on taxpayers' investment.'
The Policy's 'all' refers to the whole of the U.S. population, as well as 'populations in low- and middle-income countries.
#nih-access-plan-policy #federally-funded-inventions #commercialization #partnerships #bayh-dole-act
[
Collection
]
[
|
...
]